ÂÜÀòÂÒÂ×

George Montgomery is currently a Senior Advisor at Alvarium since April 2022. George is also a Board Member at Alladapt Immunotherapeutics, Inc. and serves as the Chief Financial Officer at Retromer Therapeutics and NEUVOGEN, Inc. With a background in finance and business administration, George has held various leadership roles in companies like WestRiver Group, Ashvattha Therapeutics, Lumen Bioscience, Viome, Crossover Health, and BEFORE Brands, Inc. George holds an MBA in Finance from The Wharton School and a BA in Political Science from Yale University.